WORLD VIEW BLOG: Austerity-driven off-label prescribing must stop
This article was originally published in Scrip
Executive Summary
It is worrying to observe how countries in Europe are increasingly challenging harmonized EU rules on authorizing drugs for the sake of cutting costs in their national health systems. It seems that in particular, off-label prescribing is now seen as a good way to make savings in healthcare spending. This hasn't always been the case. Off-label prescribing was largely limited to cases where no authorized treatment existed. In times of austerity, however, this has clearly changed.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.